The Effect of Sugammadex During Transcranial Electrical Motor Evoked Potential Monitoring in Spinal Surgery

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 16, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Sugammadex
Interventions
DRUG

Sugammadex

Sugammadex group received a rocuronium infusion producing blockade by qualitative train-of-four ≥2 at the ulnar nerve. 2 mg/kg of Sugammadex will be infused when conducting TcMEP

Trial Locations (1)

100070

Beijing Tiantan Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT04471376 - The Effect of Sugammadex During Transcranial Electrical Motor Evoked Potential Monitoring in Spinal Surgery | Biotech Hunter | Biotech Hunter